Digitisation | December 22, 2023
Digital transformation key to managing rising organisational healthcare costs in India
Employer-sponsored health insurance costs in India are expected to rise by 11% in 2024
Employer-sponsored health insurance costs in India are expected to rise by 11% in 2024
Development services for gene and cell therapies is planned to begin first in 2025
Anticipates approx. US$8 billion in revenues for Comirnaty and Paxlovid
Cresemba is the only azole antifungal therapy approved for pediatric patients as young as one affected by these serious, potentially life-threatening infections
South Asia’s largest Trade Fair for pharma brought together over 50,000 visitors from across the globe, more than 1,500 exhibitors showcasing 10,000+ products and representation from over 80 countries
Final stage in licensing OVM-200 from Oxford Vacmedix in the UK
Emphasizes the need for a collective effort on bolstering resilience across economies, societies, healthcare systems, education systems and infrastructure
The company has raised US$4.5 million in funding for its AI operating system
Lack of technology transfer stands out as a formidable barrier
Revenue in the three months ended on Oct. 1 also slipped by 42% to US$ 13.23 billion
Subscribe To Our Newsletter & Stay Updated
